Boris Fehse Selected Research

Boris Fehse Research Topics

Disease

34	Neoplasms (Cancer) 12/2023 - 12/2004
13	Primary Myelofibrosis (Myelosclerosis) 07/2023 - 03/2005
12	Multiple Myeloma 01/2020 - 08/2002
6	Neoplasm Metastasis (Metastasis) 12/2023 - 04/2012
6	Leukemia 03/2022 - 06/2005
6	Infections 01/2021 - 05/2010
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2013 - 08/2002
5	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 08/2008
4	Residual Neoplasm 01/2022 - 05/2006
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2013 - 01/2009
3	Disease Progression 03/2024 - 01/2011
3	Multiple Sclerosis 03/2024 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 05/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 03/2020
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 08/2008
3	Lymphoma (Lymphomas) 01/2021 - 12/2004
2	cell-associated neurotoxicity 01/2023 - 12/2021
2	Body Weight (Weight, Body) 05/2022 - 08/2008
2	Thrombocytopenia (Thrombopenia) 12/2021 - 12/2021
2	HIV Infections (HIV Infection) 01/2021 - 01/2013
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2013
2	Glioma (Gliomas) 11/2019 - 12/2010
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 01/2014
2	Breast Neoplasms (Breast Cancer) 03/2015 - 12/2010
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011 - 01/2008
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2024
1	Liver Neoplasms (Liver Cancer) 12/2023
1	Pathologic Constriction (Stenosis) 10/2023
1	Liver Diseases (Liver Disease) 10/2023
1	Sclerosing Cholangitis 10/2023
1	COVID-19 01/2022
1	Inflammation (Inflammations) 12/2021
1	Neutropenia 12/2021
1	Cytokine Release Syndrome 12/2021
1	Thrombosis (Thrombus) 12/2021

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 12/2023 - 05/2015
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2005
6	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 08/2008 - 12/2002
5	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2020
4	axicabtagene ciloleucelIBA 05/2022 - 03/2020
4	EpitopesIBA 01/2020 - 06/2013
4	ErbB Receptors (EGF Receptor)IBA 11/2019 - 05/2015
3	CytokinesIBA 12/2023 - 04/2012
3	Busulfan (Busulfex)FDA Link 05/2022 - 03/2005
3	VaccinesIBA 01/2022 - 12/2021
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2017
3	Thymidine KinaseIBA 11/2019 - 12/2004
3	ProdrugsIBA 11/2019 - 01/2013
3	Cetuximab (Erbitux)FDA Link 01/2019 - 05/2015
3	AntigensIBA 01/2016 - 01/2013
2	CD19-specific chimeric antigen receptorIBA 01/2023 - 07/2020
2	tisagenlecleucelIBA 05/2022 - 12/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2021 - 12/2017
2	Monoclonal AntibodiesIBA 01/2020 - 08/2014
2	EnzymesIBA 01/2020 - 12/2015
2	Ganciclovir (Cytovene)FDA LinkGeneric 11/2019 - 12/2004
2	Panitumumab (Vectibix)FDA Link 01/2019 - 05/2015
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016 - 06/2013
2	Ciliary Neurotrophic Factor (CNTF)IBA 09/2014 - 12/2013
2	fludarabineIBA 03/2005 - 12/2002
1	Sorafenib (BAY 43-9006)FDA Link 12/2023
1	GoldIBA 12/2023
1	Interferon-alpha (Interferon Alfa)IBA 12/2023
1	Fluorouracil (Carac)FDA LinkGeneric 12/2023
1	Interleukin-10 ReceptorsIBA 12/2023
1	Axitinib (AG 013736)IBA 12/2023
1	Interleukin-10 (Interleukin 10)IBA 12/2023
1	HLA-DPA1 antigen (HLA DPA1)IBA 10/2023
1	sulfolaneIBA 05/2022
1	Glutathione Transferase (Glutathione S-Transferase)IBA 05/2022
1	Epithelial Cell Adhesion MoleculeIBA 04/2022
1	Surface Antigens (Surface Antigen)IBA 04/2022
1	p38 Mitogen-Activated Protein KinasesIBA 04/2022
1	MTOR InhibitorsIBA 04/2022
1	C-Reactive ProteinIBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 12/2021
1	Ferritins (Ferritin)IBA 12/2021
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	ChAdOx1 nCoV-19IBA 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Transcription Activator-Like EffectorsIBA 01/2021
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2021
1	Signaling Lymphocytic Activation Molecule FamilyIBA 01/2021
1	Transcription Activator-Like Effector NucleasesIBA 01/2021
1	Chemokine ReceptorsIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021

Therapy/Procedure

21	Stem Cell Transplantation 01/2023 - 08/2002
19	Therapeutics 03/2024 - 12/2005
12	Transplantation 12/2023 - 12/2002
6	Hematopoietic Stem Cell Transplantation 05/2022 - 12/2010
5	Drug Therapy (Chemotherapy) 01/2021 - 12/2010
4	Immunotherapy 12/2023 - 07/2009
3	Homologous Transplantation 09/2010 - 11/2004
1	Immunomodulation 03/2024
1	Liver Transplantation 10/2023
1	Cell Transplantation 07/2023